Page last updated: 2024-11-05

tranexamic acid and Brain Concussion

tranexamic acid has been researched along with Brain Concussion in 2 studies

Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.

Brain Concussion: A nonspecific term used to describe transient alterations or loss of consciousness following closed head injuries. The duration of UNCONSCIOUSNESS generally lasts a few seconds, but may persist for several hours. Concussions may be classified as mild, intermediate, and severe. Prolonged periods of unconsciousness (often defined as greater than 6 hours in duration) may be referred to as post-traumatic coma (COMA, POST-HEAD INJURY). (From Rowland, Merritt's Textbook of Neurology, 9th ed, p418)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Williams, J1
Ker, K1
Roberts, I1
Shakur-Still, H1
Miners, A1
Rostami, E1
Kongstad, P1
Marklund, N1

Trials

1 trial available for tranexamic acid and Brain Concussion

ArticleYear
A cost-effectiveness and value of information analysis to inform future research of tranexamic acid for older adults experiencing mild traumatic brain injury.
    Trials, 2022, May-03, Volume: 23, Issue:1

    Topics: Aged; Brain Concussion; Cost-Benefit Analysis; Humans; Quality-Adjusted Life Years; Tranexamic Acid;

2022

Other Studies

1 other study available for tranexamic acid and Brain Concussion

ArticleYear
[Should all patients with traumatic brain injury receive tranexamic acid?]
    Lakartidningen, 2020, 10-05, Volume: 117

    Topics: Antifibrinolytic Agents; Brain Concussion; Brain Injuries, Traumatic; Double-Blind Method; Humans; R

2020